It has been conclusively demonstrated that obesity triggers NLRP3 activation and that secreted IL-1β that impairs insulin signaling, which contributes to IR in mice (Mori et al., 2011; Rea et al., 2018). The gene discussed is NLRP3; the disease is obesity disorder.